EP2825241A1 - Guidewire with integral radiopaque markers - Google Patents
Guidewire with integral radiopaque markersInfo
- Publication number
- EP2825241A1 EP2825241A1 EP13708290.5A EP13708290A EP2825241A1 EP 2825241 A1 EP2825241 A1 EP 2825241A1 EP 13708290 A EP13708290 A EP 13708290A EP 2825241 A1 EP2825241 A1 EP 2825241A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- guidewire
- inner core
- erosion
- channels
- outer layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23F—NON-MECHANICAL REMOVAL OF METALLIC MATERIAL FROM SURFACE; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL; MULTI-STEP PROCESSES FOR SURFACE TREATMENT OF METALLIC MATERIAL INVOLVING AT LEAST ONE PROCESS PROVIDED FOR IN CLASS C23 AND AT LEAST ONE PROCESS COVERED BY SUBCLASS C21D OR C22F OR CLASS C25
- C23F4/00—Processes for removing metallic material from surfaces, not provided for in group C23F1/00 or C23F3/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09058—Basic structures of guide wires
- A61M2025/09075—Basic structures of guide wires having a core without a coil possibly combined with a sheath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09108—Methods for making a guide wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09133—Guide wires having specific material compositions or coatings; Materials with specific mechanical behaviours, e.g. stiffness, strength to transmit torque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09166—Guide wires having radio-opaque features
Definitions
- Embodiments hereof are directed to a guidewire having integral radiopaque markers formed therein.
- Medical guidevvires are used in numerous catheterization procedures as an aid to placement of a catheter and/or prosthesis at a selected site within a body lumen.
- the catheter is constructed to perform a particular procedure at that internal site.
- guidewire is in the catheterization of blood vessels for diagnostic or therapeutic vaposes.
- the guidewire is inserted, usually percutaneously, into one of the patient's blood vessels and is manipulated and advanced through the branches of the vascular system to the target site.
- the diagnostic or treatment catheter is then threaded over and advanced along the guidewire, with the guidewire serving to guide the catheter directly to the target site.
- a measuring or marker catheter is required to accurately determine the length of vasculature that requires treatment prior to insertion of the diagnostic or treatment catheter. More particularly, after the guidewire is positioned within the vasculature, a marker catheter is passed over the guidewire to the site of treatment. The marker catheter is provided with a plurality of radiopaque marker bands that are utilized to make in situ measurements and determine the length of vasculature that requires treatment. The marker catheter is removed. With the measurements, the appropriate size of an implant or prosthesis required for the treatment site may be selected.
- An implant or prosthesis which may be utilized in treatment or diagnostics of the treatment site may be a stent, a stent graft, a filter, an occlusion device or other implantable device.
- the selected implant is then delivered to the treatment site using a second catheter that is passed over the indwelling guidewire.
- a patient's baseline typically refers to a patient's condition prior to a clinical procedure or intervention, and thus is the control used for comparison purposes after the clinical treatment is applied.
- the catheter may cause damage to the patient's vessels during introduction, tracking, and manipulation.
- the exchange of several catheter devices may yield more or additional damage or irritation to the areas of contact, including the introduction site and internal surfaces of vessels.
- Embodiments hereof are related to a guidewire that combines the delivery guidewire and the dimensioning catheter in order to reduce patient impact and costs associated with an endovascular interventional procedure.
- Embodiments hereof relate to a method of manufacturing a guidewire having a plurality of integral radiopaque markers formed therein.
- the method includes providing an elongated wire having an outer layer and an inner core, wherein the inner core is formed from a radiopaque material susceptible to erosion by an erosion agent and the outer layer is formed from a material non susceptible to erosion by the erosion agent. Channels are formed through the outer layer to expose the inner core. Via the channels, the inner core is subjected to the erosion agent and segments of the inner core adjacent to the channels are eroded, thereby forming a plurality of integral radiopaque markers and a plurality of voids therebetween.
- Embodiments hereof also relate to a guidewire formed from an elongated shaft having an outer layer and an inner core.
- the inner core is formed from a radiopaque material susceptible to erosion by an erosion agent and the outer layer is formed from a material non susceptible to erosion by the erosion agent.
- the inner core is solid and continuous along a proximal portion of the shaft but the inner core is non-continuous along a marker portion of the shaft.
- the marker portion of the shaft includes a plurality of segments of the radiopaque material with a plurality of voids therebetween. The marker portion is di stal to the proximal portion of the shaft.
- FIG. 1 is a side view of an embodiment of a guidewire having a marker portion with a plurality of integral radiopaque markers.
- FIG. 1A is a cross-sectional view taken along line A-A of FIG. 1 within a proximal portion of the guidewire.
- FIG. I B is a sectional view taken along line B-B of FIG. 1 within a marker portion of the guidewire.
- FIG, IC is a sectional view taken along line B-B of FIG. 1, illustrating another embodiment of a marker portion of a guidewire.
- FIG. I D is a cross-sectional view taken along line D-D of FIG. 1 within a distal tip portion of the guidewire.
- FIG. IE is a side view illustrating another embodiment of a distal tip portion of a guidewire.
- FIG. I F is a side view illustrating another embodiment of a distal tip portion of a guidewire.
- FIG. 2 is a side view of an embodiment of a guidewire having multiple marker portions, each marker portion including a plurality of integral radiopaque markers.
- FIG, 3 is a flow chart illustrating an embodiment of a method of manufacturing a guidewire having a marker portion with a plurality of integral radiopaque markers.
- distal and proximal are used in the following description with respect to a position or direction relative to the treating clinician.
- distal or disally are a position distant from or in a direction away from the clinician.
- Proximal and “proximally” are a position near or in a direction toward the clinician.
- erode or "erosion” of inner core material as utilized herein is intended to encompass erosion, corrosion, disintegration, dissolution, or similar methodologies in which a particular processing material, hereinafter referred to as a "erosion agent,” removes finite amounts or segments of a material ,
- FIG. 1 illustrates a steerable guidewire 100 which includes a proximal portion 108, a distal tip portion 112, and an intermediate marker portion 110 extending therebetween.
- marker portion 1 10 includes a series of integral radiopaque segments or markers 118 having voids or gaps 116 therebetween. Integral radiopaque markers 118 are visible under fluoroscopy and may thus be utilized for intravascular measurement, as well as assisting in alignment against or co-axial to a vessel wall.
- guidewire 100 By including a series of integral radiopaque markers 1 18, guidewire 100 combines a delivery guidewire and a marker or measurement catheter into a single device.
- integral radiopaque markers 118 are positioned within, i.e., in the interior of, guidewire 100.
- Such interior radiopaque markers have several advantages over radiopaque markers that are attached to an exterior surface of an intravascular device, including both guidewires or catheters.
- radiopaque markers must be held in position which requires extra manufacturing steps, may require a cover or coating to isolate the markers from the exterior or tracking surface of the guidewire, and may have reliability concerns because the exterior radiopaque markers may dislodge or cause hold-up of the intravascular device.
- radiopaque markers 118 are integrally formed as a part of guidewire 100 and do not require any component or structure to hold markers 118 in place. Further, by forming radiopaque markers 1 18 within or interior to guidewire 100, the exterior or tracking surface of guidewire 100 is smooth and radiopaque markers 1 18 are isolated from the tracking surface without any additional manufacturing steps.
- Guidewire 100 is formed from an elongated guide wire shaft 102 which is a coextruded or composite wire having an inner core 106 and an outer shell or layer 104.
- the materials of inner core 106 and outer layer 104 provide guidewire shaft 102 with sufficient column strength to be pushed through a patient's vascular system without kinking and also with enough flexibility to avoid damaging the blood vessel or other body lumen through which guidewire 100 is advanced. Further, guidewire 100 has the flexibility and strength required to iiitravascuiarly deliver a therapeutic or diagnostic device such as a catheter.
- Each material utilized for inner core 106 and outer layer 104 has different properties which either attenuate x-ray radiation or provide strength to guidewire 100. More particularly, the material for inner core 106 is a radiopaque material, thus visible under x-ray or fluoroscopic imaging equipment, while the material for outer layer 104 provides sufficient strength and flexibility to guidewire 100.
- the material of inner core 106 is susceptible to erosion by an erosion agent while the material of outer layer 104 is not susceptible to erosion by the erosion agent.
- the material of inner core 106 is a sacrificial materia! that can be removed by a process that does not damage the material of outer layer 104.
- a series of integral radiopaque markers 1 1 8 may be formed within marker region 110 of guidewire 100 as will be described in more detail herein.
- Non-exhaustive examples of the material of inner core 106 include but are not limited to tungsten, tantalum, platinum, platinum and iridium alloy, rhenium, gold, molybdenum, silver, and alloys containing one or more thereof.
- Non-exhaustive examples of the material of outer layer 104 include but are not limited to stainless steel alloys, chromium cobalt alloys, and nickel titanium alloys such as Nitinol. Exemplary combinations of materials for the inner core, the outer layer, and the erosion agent are discussed in more detail herein with respect to FIG. 3.
- proximal portion 108 is formed from the coextmded or composite wire having outer layer 104 and a solid or continuous inner core 106.
- An outer diameter Do of guidewire shaft 102 along proximal portion 108 may be constant. In one embodiment, outer diameter Do is 0.014 inch, 0.018 inch, or 0.035 inch although other dimensions are possible.
- the relative thicknesses of inner core 106 and outer layer 104 vary depending on the application, specific requirements for flexibility, specific requirements of treatment or diagnostic devices delivered there over, and/or desired radiopacity levels. In one embodiment, the thickness of outer layer 104 ranges from 50 to 90 percent of the cross-sectional diameter of the wire.
- proximal portion 108 may include only a single, solid material. More particularly, the coextnxded or composite wire utilized for guidewire shaft 102 may include a transition area within proximal portion 108 in which the material for outer layer 104 becomes the only material of guidewire shaft 102 and the material for inner core 106 is no longer present. Such a portion having only a single, solid material may be positioned in regions of the guidewire where inflexibility is desired and radiopacity is not desired, such as the most proximal portion of the guidewire. Such portions may be integral with the remainder of the guidewire shaft or may be a separate piece connected to the remainder of the guidewire through welding or other appropriate mechanical connections.
- Distal tip portion 1 12 is also formed from the coextruded or composite wire having outer layer 104 and a solid or continuous inner core 106, as shown in the sectional view of FIG. I D.
- the outer diameter of guidewire shaft 102 along distal tip portion 112 is tapered in order to be very flexible or "floppy" and capable of conforming to and following the contours of highly tortuous vascular anatomy. More particularly, as shown in FIG. I D, the outer diameter of guidewire shaft 102 decreases in a distal direction from outer diameter D 0 to a distal tip diameter D-r. In one embodiment shown in FIG.
- distal tip portion 112 may have other constructions which result in a flexibility suitable for accessing vascular anatomy without damage thereto.
- the distal tip portion may alternatively include a stepped taper as shown in FIG. IF. More particularly, distal tip portion 112F includes a guidewire shaft 102 in which the outer diameter decreases in a distal direction from outer diameter Do to a distal tip diameter Dj in a stepped or incremental manner.
- tapered distal tip portion 1 12F may be supplemented with a polymer coating or jacket that makes the outer diameter of guidewire shaft 102 constant along the length of tapered distal portion 112F.
- a distal tip portion 112E includes a helical element or coil 122 attached to and extending about tapered distal portion 112E of guidewire shaft 102.
- the portion of guidewire shaft 102 that extends within coil 122 may include both inner core material 106 and outer layer 104, although the layers are not shown in FIG. IE.
- the portion of guidewire shaft 102 that extends within coil 122 acts as a core or inner member for coil 122 and the presence of coil 122 results in distal region of increasing flexibility that is adapted to follow the contours of the vascular anatomy while still being capable of transmitting rotation from the proximal end of the guidewire to the distal end, so that the physician can controllably steer the guidewire through the patient's blood vessels.
- the portion of guidewire shaft 102 that extends within coil 122 may have a smaller outer diameter than the remainder of guidewire 102.
- the portion of guidewire shaft 102 that extends within coil 122 may include an inner core material that continuously or incrementally tapers in a distal direction as described above with respect to FIG. ID and FIG.
- the end or tip of the distal tip portion may ⁇ be rounded as shown in FIG. ID, may include a separate semi-circular tip component 124 as shown in FIG. IE, or alternatively may be relatively blunt or pointed as shown in FIG. IF. Further, although shown as integral!' formed with guidewire shaft 102, in another embodiment (not shown), the distal tip portion may be a separate component that is mechanically coupled to guidewire shaft 102,
- marker portion 110 includes outer layer 104 and a non-continuous inner core 106 that forms the plurality of integral radiopaque markers 118.
- Marker portion 1 10 is formed by exposing guidewire shaft 102 to the erosion agent, which accesses inner core 106 via a plurality of openings or channels 1 14.
- Channels 114 are holes which extend through outer layer 104 in order to expose inner core 106 and are longitudinally spaced along marker portion 1 10.
- the erosion agent erodes finite amounts of the inner core material adjacent to each channel 114, thereby removing segments of the inner core materia! adjacent to each channel 114 and forming voids 116.
- Integral radiopaque markers 118 are thereby formed by the remaining segments of the inner core material which are positioned between voids 1 16.
- the pattern or sequence of voids 116 and integral radiopaque markers 118 provide a means of in situ measurement when viewed under fluoroscopy.
- marker portion 1 10 may be between 20 cm and 40 cm in length and is positioned just proximal to distal tip portion 1 12, which may range between 5 cm and 20 cm in length depending on the application.
- Guidewire 102 thus includes three portions of increasing flexibility, with proximal portion 108 having the least flexibility, distal tip portion 112 having the most flexibility, and intermediate marker portion 108 sandwiched therebetween.
- the overall length of guidewire 100 may be between 180 cm and 300 cm.
- Guidewire 102 is exposed to the erosion agent for a predetermined amount of time to result in a desired/predicted length of each void 116. More particularly, the rate of erosion of the inner core material is known and predictable for a particular combination of materials. The amount of time which guidewire shaft 102 is exposed to the erosion agent thus depends upon the materials chosen for inner core 106 and the erosion agent. In addition, the spacing between each channel 1 14 is selected or designed based on the desired/predicted length of radiopaque markers 1 18 and the desired/predicted length of each void 1 18. Accordingly, by controlling the amount of time which guidewire 102 is exposed to the erosion agent, accurate and distinct marker spacing may be achieved. In one embodiment shown in FIG.
- the size of voids 116 are relatively smaller than the size of markers 1 18.
- guidewire 100 maintains its structural integrity while providing a series of integral radiopaque markers therein for in situ measurement.
- the above-described dimensions of marker portion 110, radiopaque markers 1 18, voids 116, and other components of guidewire 100 are exemplary and may vary according to application.
- the size of markers 1 18C are relatively smaller than the size of voids 116C.
- each radiopaque marker 118C may be approximately 2 mm in length and each void 116C may be approximately 8 mm in length. The consecutive application of markers and voids at this spacing yields radiopaque markers spaced at 10 mm from marker center to marker center.
- marker portion 1 IOC provides a series of integral radiopaque markers for in situ measurement while having increased flexibility due to the relatively larger size of voids 1 16C.
- the size of each radiopaque marker may be approximately equal to the size of each void.
- the length of each radiopaque marker may be between 20% and 150% of the length of each void. The relative sizes of each radiopaque marker and each void depend upon the desired flexibility of the marker portion for a particular application.
- FIG. 1 illustrates a guidewire having a single marker portion having a series of radiopaque markers
- multiple marker portions may be formed along the length of the guidewire if desired.
- a guidewire 200 is shown having two marker portions 21 OA, 21 OB spaced apart along the length of guidewire 200.
- Each marker portion 21 OA, 210B include a non-continuous inner core forming a series of radiopaque markers (not shown in FIG. 2) and voids (not shown in FIG. 2) therebetween, as described above with respect to FIG. I B.
- Marker portion 210B is positioned just proximal to distal tip portion 212, while marker portion 210A is positioned between two proximal portions 208A, 208B. Having multiple marker portions along the length of guidewire 200 provides additional means of in situ measurement. Since marker portions are formed by eroding segments of inner core material, it will be understood by those of ordinary skill in the art that integral radiopaque markers may advantageously be formed at essentially any location on the guidewire. Multiple marker portions, each having different spacing between and/or length(s) of radiopaque markers, may selectively be placed along the length of the guidewire shaft.
- FIG. 3 is a flow chart illustrating a method of manufacturing guidewire 100 having integral radiopaque markers 1 18.
- An initial step 320 includes providing a coextruded or composite elongated wire having outer layer 104 and inner core 106 which forms the basis of guidewire shaft 102.
- a coextruded or composite wire may be formed by any method known in the art, for example and not by way of limitation, a drawn filled tubing process, extruding the outer layer over the inner core, or any other suitable method. Examples of such wires and methods of forming such wires can be found in U.S. Pat. No. 5,630,840 to Mayer, U.S. Pat. No. 6,248,190 to Stinson, U.S. Pat. No. 6,497,709 to Heath, and U.S. Pat. No. 7,101,392 to Heath, each of which is incorporated by reference herein in its entirety.
- Step 330 of FIG. 3 is creating openings or channels 114 in outer layer 104 in order to expose inner core 106.
- Channels 1 14 may be selectively formed at any location along the length of guidewire shaft 102 that is to include radiopaque markers.
- guidewire 100 may include multiple marker portions along the length thereof with each marker portion including a plurality of integral radiopaque markers.
- two longitudinally-aligned rows of channels 1 14 are positioned on opposing sides of guidewire shaft 102 such that the rows are positioned approximately 180 degrees apart. As described above, the spacing between channels 1 14 may vary depending upon application but should be spaced apart as desired to form radiopaque markers suitable for in situ measurement.
- Channels 114 may be laser cut, drilled, etched, or otherwise provided in outer layer 104 and have a depth at least equal to the thickness of outer layer 104.
- channels 114 may have a circular, oval, rectangular, or any other suitable cross-section and in one embodiment, may have a diameter or width that ranges between a few and hundreds of microns, up to 1 ⁇ 2 of the outer diameter of guidewire 100.
- radiopaque markers 118 guidewire shaft 102 is subjected to an erosion agent that erodes segments of the inner core material to form a pattern of integral radiopaque markers 118 and voids 116 therebetween as shown in step 340.
- the erosion agent accesses inner core 104 via channel s 1 14 and erodes fini te amounts or segments of the inner core material adjacent to channels 114.
- the material for inner core 106 is tungsten or rhenium
- the material for outer layer 104 is NiTi (Nitinol)
- the erosion agent is xenon difluoride gas.
- the material for outer layer 104 is MP35N.
- inner core 106 (tungsten or rhenium) is eroded by subjecting guidewire shaft 102 to xenon difluoride gas in a vacuum which reacts with the core material to form a gas that can be exhausted from the guidewire shaft via channels 114.
- xenon difluoride gas does not react with NiTi (Nitinol) or MP35N such that the outer layer 104 remains after segments of the inner core 106 have been removed, leaving the structure shown in FIG. I B.
- bromine tri fluoride or other interhalogen gases can be used as the erosion agent instead of xenon difluoride.
- channels 114 may be closed or filled in after radiopaque markers 1 18 are formed.
- Channels 1 14 may be filled as a separate manufacturing step, or may be filled in during application of a low-friction coating applied to the outer surface of guidewire 100, such as a coating of PTFE. With channels 1 14 filled in or covered, any discontinuities in the outer surface of guidewire 100 are eliminated, thereby eliminating or minimizing performance-related issues with 'catching' or friction of a treatment device slid or tracked over the outer surface of guidewire 100.
- channels 1 14 may be left open after radiopaque markers 118 are formed .
- Channels 114 may be of a sufficiently small diameter that the edges thereof do not create surface discontinuities of concern. Leaving channels 114 open minimizes manufacturing costs and may increase the flexibility of the guidewire in the marker portion. For example, the diameters of channels 114 may be sized appropriately to make marker portion 110 of guidewire 100 more flexible.
- outer layer, inner core, and erosion agent combinations include but are not limited to an outer layer of Nitinol or stainless steel, an inner core of gold, and an erosion agent of potassium triiodide. These examples are illustrative and it would be understood by one skilled in the art that an erosion agent that reacts with the material of the inner core to erode the core material but does not react with the material of an outer layer may be used in step 340 to form a series of integral radiopaque markers within guidewire 100.
- an erosion agent that reacts with the material of the inner core to erode the core material but does not react with the material of an outer layer may be used in step 340 to form a series of integral radiopaque markers within guidewire 100.
- the hollow struts are formed from a composite wire or member including an outer member and a core member, wherein the core member is a sacrificial material that is removed after shaping the composite wire into a desired shape. It will be understood by those of ordinary skill in the art. that combinations of the inner member, the outer member, and the erosion agent and manufacturing steps for removing the core member described in the above-mentioned patent applications may be utilized in forming a guidewire having a series of integral radiopaque markers as described herein.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/418,092 US9358370B2 (en) | 2012-03-12 | 2012-03-12 | Guidewire with integral radiopaque markers |
| PCT/US2013/026535 WO2013138018A1 (en) | 2012-03-12 | 2013-02-16 | Guidewire with integral radiopaque markers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2825241A1 true EP2825241A1 (en) | 2015-01-21 |
| EP2825241B1 EP2825241B1 (en) | 2019-04-03 |
Family
ID=47843407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP13708290.5A Active EP2825241B1 (en) | 2012-03-12 | 2013-02-16 | Guidewire with integral radiopaque markers |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US9358370B2 (en) |
| EP (1) | EP2825241B1 (en) |
| WO (1) | WO2013138018A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10441754B2 (en) * | 2014-03-26 | 2019-10-15 | Volcano Corporation | Intravascular devices, systems, and methods having a core wire formed of multiple materials |
| DE202015101591U1 (en) * | 2015-03-30 | 2015-06-11 | Cormedics Medizintechnik GmbH | Medical measuring wire |
| US11071576B2 (en) * | 2015-10-27 | 2021-07-27 | Spinal Simplicity, Llc | Flexible guide wire with tantalum marker |
| DE102018203102B3 (en) * | 2018-03-01 | 2019-05-16 | Epflex Feinwerktechnik Gmbh | Guidewire for medical MR applications |
| US12005205B2 (en) * | 2019-12-16 | 2024-06-11 | Stryker Corporation | Guidewires for medical devices |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4719924A (en) * | 1986-09-09 | 1988-01-19 | C. R. Bard, Inc. | Small diameter steerable guidewire with adjustable tip |
| US5106455A (en) * | 1991-01-28 | 1992-04-21 | Sarcos Group | Method and apparatus for fabrication of micro-structures using non-planar, exposure beam lithography |
| US6107004A (en) | 1991-09-05 | 2000-08-22 | Intra Therapeutics, Inc. | Method for making a tubular stent for use in medical applications |
| US7101392B2 (en) | 1992-03-31 | 2006-09-05 | Boston Scientific Corporation | Tubular medical endoprostheses |
| US6497709B1 (en) | 1992-03-31 | 2002-12-24 | Boston Scientific Corporation | Metal medical device |
| US5630840A (en) | 1993-01-19 | 1997-05-20 | Schneider (Usa) Inc | Clad composite stent |
| US5776100A (en) * | 1995-09-27 | 1998-07-07 | Interventional Innovations Corporation | Nickel titanium guide wires for occlusion and drug delivery |
| US20030069522A1 (en) * | 1995-12-07 | 2003-04-10 | Jacobsen Stephen J. | Slotted medical device |
| WO1999065623A1 (en) | 1998-06-15 | 1999-12-23 | Scimed Life Systems, Inc. | Process of making composite stents with gold alloy cores |
| US6387060B1 (en) * | 1998-06-17 | 2002-05-14 | Advanced Cardiovascular Systems, Inc. | Composite radiopaque intracorporeal product |
| US6391502B1 (en) | 1998-09-23 | 2002-05-21 | Pemstar, Inc. | Photolithographic process for producing etched patterns on the surface of fine tubes, wires or other three dimensional structures |
| US6520934B1 (en) * | 1999-12-29 | 2003-02-18 | Advanced Cardiovascular Systems, Inc. | Catheter assemblies with flexible radiopaque marker |
| DE10025550A1 (en) * | 2000-05-19 | 2001-11-29 | Infineon Technologies Ag | Plasma etching process used in the production of Fe-RAMs comprises applying a polyimide mask before the structure is etched |
| US6554848B2 (en) * | 2000-06-02 | 2003-04-29 | Advanced Cardiovascular Systems, Inc. | Marker device for rotationally orienting a stent delivery system prior to deploying a curved self-expanding stent |
| US6620114B2 (en) | 2000-10-05 | 2003-09-16 | Scimed Life Systems, Inc. | Guidewire having a marker segment for length assessment |
| US6636758B2 (en) | 2001-05-01 | 2003-10-21 | Concentric Medical, Inc. | Marker wire and process for using it |
| US7878984B2 (en) * | 2002-07-25 | 2011-02-01 | Boston Scientific Scimed, Inc. | Medical device for navigation through anatomy and method of making same |
| US8167821B2 (en) * | 2003-02-26 | 2012-05-01 | Boston Scientific Scimed, Inc. | Multiple diameter guidewire |
| US7989042B2 (en) * | 2004-11-24 | 2011-08-02 | Boston Scientific Scimed, Inc. | Medical devices with highly flexible coated hypotube |
| US20070135732A1 (en) | 2005-12-13 | 2007-06-14 | Cook Incorporated | Flexible mandril |
| US8419658B2 (en) * | 2006-09-06 | 2013-04-16 | Boston Scientific Scimed, Inc. | Medical device including structure for crossing an occlusion in a vessel |
| US9339632B2 (en) * | 2006-09-27 | 2016-05-17 | Boston Scientific Scimed, Inc. | Catheter shaft designs |
| US8556914B2 (en) * | 2006-12-15 | 2013-10-15 | Boston Scientific Scimed, Inc. | Medical device including structure for crossing an occlusion in a vessel |
| US9387308B2 (en) * | 2007-04-23 | 2016-07-12 | Cardioguidance Biomedical, Llc | Guidewire with adjustable stiffness |
| US9808595B2 (en) * | 2007-08-07 | 2017-11-07 | Boston Scientific Scimed, Inc | Microfabricated catheter with improved bonding structure |
| US20090112127A1 (en) * | 2007-10-27 | 2009-04-30 | Salviac Limited | Nitinol guidewire |
| US7806837B2 (en) | 2007-11-07 | 2010-10-05 | William Cook Europe Aps | Guide wire for catheter |
| US8376961B2 (en) * | 2008-04-07 | 2013-02-19 | Boston Scientific Scimed, Inc. | Micromachined composite guidewire structure with anisotropic bending properties |
| US8070694B2 (en) * | 2008-07-14 | 2011-12-06 | Medtronic Vascular, Inc. | Fiber based medical devices and aspiration catheters |
| US20100063479A1 (en) | 2008-09-10 | 2010-03-11 | Boston Scientific Scimed, Inc. | Small profile, tubular component design and method of manufacture |
| US8795254B2 (en) * | 2008-12-10 | 2014-08-05 | Boston Scientific Scimed, Inc. | Medical devices with a slotted tubular member having improved stress distribution |
| US9616195B2 (en) * | 2009-04-03 | 2017-04-11 | Scientia Vascular, Llc | Micro-fabricated catheter devices having varying diameters |
| US8137293B2 (en) * | 2009-11-17 | 2012-03-20 | Boston Scientific Scimed, Inc. | Guidewires including a porous nickel-titanium alloy |
| US20120244715A1 (en) * | 2009-12-02 | 2012-09-27 | Xactix, Inc. | High-selectivity etching system and method |
| US20110144689A1 (en) * | 2009-12-15 | 2011-06-16 | Med Institute, Inc. | Occlusion Device |
| KR20130054952A (en) * | 2010-04-14 | 2013-05-27 | 마이크로벤션, 인코포레이티드 | Implant delivery device |
| WO2012106628A1 (en) * | 2011-02-04 | 2012-08-09 | Boston Scientific Scimed, Inc. | Guidewires and methods for making and using the same |
-
2012
- 2012-03-12 US US13/418,092 patent/US9358370B2/en active Active
-
2013
- 2013-02-16 WO PCT/US2013/026535 patent/WO2013138018A1/en not_active Ceased
- 2013-02-16 EP EP13708290.5A patent/EP2825241B1/en active Active
-
2016
- 2016-05-09 US US15/149,882 patent/US10722689B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013138018A1 (en) | 2013-09-19 |
| US20160250450A1 (en) | 2016-09-01 |
| EP2825241B1 (en) | 2019-04-03 |
| US9358370B2 (en) | 2016-06-07 |
| US10722689B2 (en) | 2020-07-28 |
| US20130237963A1 (en) | 2013-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3551273B1 (en) | Slide guide catheter | |
| US8360995B2 (en) | Wire guide | |
| US8167821B2 (en) | Multiple diameter guidewire | |
| EP1606002B2 (en) | Medical device | |
| EP1804882B1 (en) | Catheter with a pre-shaped distal tip | |
| EP2961458B1 (en) | Guide extension catheter with a retractable wire | |
| US10722689B2 (en) | Guidewire with integral radiopaque markers | |
| EP1985244A2 (en) | Interventional medical device system having a slotted section and radiopaque marker and method of making the same | |
| US20100168619A1 (en) | Combination wire guide and method of use thereof | |
| US20130274618A1 (en) | Guidewire system for use in transcatheter aortic valve implantation procedures | |
| US20080269641A1 (en) | Method of using a guidewire with stiffened distal section | |
| EP4275623A2 (en) | Detachable implantable devices | |
| US20060282112A1 (en) | Method and apparatus for enhanced electrolytic detachment | |
| JP2009273640A (en) | Guiding catheter | |
| EP2000169A2 (en) | Catheter for blood removal | |
| US8777873B2 (en) | Wire guide having a rib for coil attachment | |
| EP2244775B1 (en) | Deployment catheter and delivery system thereof | |
| JP4790349B2 (en) | catheter | |
| US20100318169A1 (en) | Delivery system for endoluminal devices | |
| JP3998918B2 (en) | Guide wire | |
| JP2006271901A (en) | Coiled contrast marker, method for manufacturing the same, and catheter | |
| JP4790366B2 (en) | Extracorporeal circulation catheter | |
| CN216022317U (en) | Radiography guide wire | |
| EP4582129A1 (en) | Distal stabilizer | |
| US20260124432A1 (en) | Distal stabilizer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20141008 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61M 25/09 20060101AFI20180919BHEP Ipc: A61L 31/14 20060101ALI20180919BHEP Ipc: A61L 31/18 20060101ALI20180919BHEP Ipc: A61L 31/02 20060101ALI20180919BHEP Ipc: C23F 4/00 20060101ALI20180919BHEP |
|
| INTG | Intention to grant announced |
Effective date: 20181022 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 1114975 Country of ref document: AT Kind code of ref document: T Effective date: 20190415 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013053256 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20190403 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1114975 Country of ref document: AT Kind code of ref document: T Effective date: 20190403 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190703 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190803 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190703 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190704 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190803 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013053256 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 |
|
| 26N | No opposition filed |
Effective date: 20200106 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20200216 |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20200229 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200216 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200229 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200229 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200216 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200229 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190403 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20250122 Year of fee payment: 13 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20250124 Year of fee payment: 13 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20250122 Year of fee payment: 13 |